Female 0 6 0 6 B-gender
of 7 9 7 9 O
18 10 12 10 12 B-lower_bound
years 13 18 13 18 I-lower_bound
and 19 22 19 22 O
older 23 28 23 28 O
of 29 31 29 31 O
any 32 35 32 35 O
race 36 40 36 40 O

Has 0 3 41 44 O
biopsy 4 10 45 51 B-treatment
- 10 11 51 52 O
proven 11 17 52 58 O
invasive 18 26 59 67 O
breast 27 33 68 74 B-cancer
cancer 34 40 75 81 I-cancer
( 41 42 82 83 O
BI 42 44 83 85 B-treatment
- 44 45 85 86 I-treatment
RADS 45 49 86 90 I-treatment
6 50 51 91 92 I-treatment
) 51 52 92 93 O

Has 0 3 94 97 O
known 4 9 98 103 O
allergy 10 17 104 111 O
to 18 20 112 114 O
Tc99 21 25 115 119 B-allergy_name
m 25 26 119 120 I-allergy_name
sestamibi 27 36 121 130 I-allergy_name

Newly 0 5 131 136 O
diagnosed 6 15 137 146 O
biopsy 16 22 147 153 B-treatment
proven 23 29 154 160 O
locoregional 30 42 161 173 O
invasive 43 51 174 182 O
breast 52 58 183 189 B-cancer
cancer 59 65 190 196 I-cancer
at 66 68 197 199 O
MD 69 71 200 202 O
Anderson 72 80 203 211 O
Cancer 81 87 212 218 O
Center 88 94 219 225 O

Patients 0 8 226 234 O
who 9 12 235 238 O
agree 13 18 239 244 O
to 19 21 245 247 O
sign 22 26 248 252 O
an 27 29 253 255 O
informed 30 38 256 264 O
consent 39 46 265 272 O
to 47 49 273 275 O
undergo 50 57 276 283 O
MBI 58 61 284 287 B-treatment

Patients 0 8 288 296 O
with 9 13 297 301 O
stage 14 19 302 307 B-cancer
T1 20 22 308 310 I-cancer
or 23 25 311 313 O
greater 26 33 314 321 O
( 34 35 322 323 O
T1 35 37 323 325 O
- 37 38 325 326 O
T4 38 40 326 328 B-upper_bound
) 40 41 328 329 O

including 0 9 330 339 O
patients 10 18 340 348 O
with 19 23 349 353 O
inflammatory 24 36 354 366 B-cancer
breast 37 43 367 373 I-cancer
cancer 44 50 374 380 I-cancer

nodal 0 5 381 386 B-chronic_disease
involvement 6 17 387 398 I-chronic_disease
( 18 19 399 400 O
N0 19 21 400 402 O
- 22 23 403 404 O
N3 24 26 405 407 O
) 26 27 407 408 O

pregnant 0 8 409 417 B-pregnancy
( 9 10 418 419 O
confirmed 10 19 419 428 O
by 20 22 429 431 O
the 23 26 432 435 O
patient 27 34 436 443 O
as 35 37 444 446 O
Imaging 38 45 447 454 O
Clinic 46 52 455 461 O
standard 53 61 462 470 O
of 62 64 471 473 O
care 65 69 474 478 O
) 69 70 478 479 O

referred 0 8 480 488 O
to 9 11 489 491 O
MD 12 14 492 494 O
Anderson 15 23 495 503 O
for 24 27 504 507 O
treatment 28 37 508 517 O
after 38 43 518 523 O
initial 44 51 524 531 O
radiologic 52 62 532 542 O
( 63 64 543 544 O
mammographic 64 76 544 556 B-treatment
, 76 77 556 557 O
sonographic 78 89 558 569 B-treatment
, 89 90 569 570 O
etc 91 94 571 574 O
. 94 95 574 575 O
) 95 96 575 576 O
exams 97 102 577 582 O
at 103 105 583 585 O
an 106 108 586 588 O
outside 109 116 589 596 O
institution 117 128 597 608 O
in 129 131 609 611 O
whom 132 136 612 616 O
NAC 137 140 617 620 O
is 141 143 621 623 O
planned 144 151 624 631 O

scheduled 0 9 632 641 O
for 10 13 642 645 O
neoadjuvant 14 25 646 657 B-treatment
chemotherapy 26 38 658 670 I-treatment
( 39 40 671 672 I-treatment
NAC 40 43 672 675 I-treatment
) 43 44 675 676 I-treatment

under 0 5 677 682 O
18 6 8 683 685 B-upper_bound
years 9 14 686 691 I-upper_bound
of 15 17 692 694 O
age 18 21 695 698 B-age

without 0 7 699 706 O
metastasis 8 18 707 717 B-cancer
( 19 20 718 719 I-cancer
M0 20 22 719 721 I-cancer
) 22 23 721 722 I-cancer
invasive 24 32 723 731 I-cancer
breast 33 39 732 738 I-cancer
cancer 40 46 739 745 I-cancer

